卒中患者认知评估量表(CASP):多中心验证研究
本研究纳入201例近期首次半球卒中患者和50名对照,验证法语版CASP的心理测量学特性。CASP具有单维结构,聚合效度和分歧效度假设得到确认,内部一致性和重测信度良好,可估计最小临床重要差异(MCID),适用于亚急性期卒中后认知障碍筛查,但严重口语理解或视觉障碍者不适用。
要点
- CASP在亚急性卒中后认知筛查中心理测量学特性良好
- CASP适用于严重运动性失语或左侧偏侧忽略患者
- 严重口语理解或视觉障碍者不适用CASP
核心结论
- CASP在亚急性卒中后认知障碍筛查中具有良好的心理测量学特性,与意大利版和韩国版一致。
研究设计与样本
- 多中心验证研究,纳入201例近期首次半球卒中患者和50名对照,卒中患者在亚急性期接受4次评估(V1至V4)。
主要发现
- CASP具有单维结构,聚合效度和分歧效度假设均得到确认,内部一致性良好,信度优秀。
- 反应度小到中等,但仍可估计最小临床重要差异(MCID)。
- 研究讨论了病理阈值的选取以及V1对V4认知变化的预测阈值。
关键数值与推荐
- 201例参与者中男性占63%,平均(标准差)年龄63(13)岁。
- CASP数据在V1/V2/V3/V4分别有199/150/133/93例可用。
临床怎么用
- CASP可用于亚急性卒中后认知障碍筛查,尤其适用于严重运动性失语或左侧偏侧忽略患者。
- 严重口语理解或视觉障碍者不应使用CASP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Mini Mental State Examination and Montreal Cognitive Assessment are commonly used as short screening batteries for assessing cognitive impairment after stroke. However, aphasia or hemispatial neglect may interfere with the results. For this reason, we developed the Cognitive Assessment scale for Stroke Patients (CASP), which takes these conditions into consideration and previously demonstrated its superiority over these scales in terms of feasibility. OBJECTIVES: Our goal was to verify the psychometric properties of the (original) French version of the CASP. METHODS: We included 201 patients with a recent first hemispheric stroke and 50 controls. Stroke patients were examined 4 times (visit 1 [V1] to visit 4 [V4]) in the subacute post-stroke phase. The structural validity of the CASP was studied by principal factorial analysis, convergent validity by comparison with several variables including a comprehensive neuropsychological assessment, divergent validity by comparison with the total score between stroke patients and controls, and sub-scores between right and left stroke. Internal consistency, reproducibility and sensitivity to change were assessed. We propose the Minimal Clinically Important Difference (MCID) value and a pathological threshold as well as a threshold to predict cognitive change between V1 and V4. RESULTS: Of the 201 participants included (63% male; mean [SD] age 63 [13] years), CASP data were available for 199/150/133/93 at V1/V2/V3/V4, respectively. CASP has a one-dimensional structure. The hypotheses of convergent/divergent validities were confirmed. Internal consistency was good and reliability excellent. Responsiveness was small to moderate, but the MCID could still be estimated. We discuss the choice of a pathological threshold and a predictive threshold of V1 over V4. CONCLUSIONS: CASP has good psychometric properties for screening cognitive impairment in the subacute post-stroke phase, which is consistent with its Italian and Korean versions. It can be used for patients with severe motor aphasia or left hemispatial neglect but not in case of severe oral comprehension or visual impairment.
引用
- Benaim C, Wauquiez G, Pérennou D, et al. Cognitive assessment scale for stroke patients (CASP): A multicentric validation study. Ann Phys Rehabil Med. 2021. PMID: 34687958. doi:10.1016/j.rehab.2021.101594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。